Skip to main content
Erschienen in: Molecular Diagnosis & Therapy 6/2017

01.12.2017 | Original Research Article

Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt

verfasst von: Rabab E. El Hawary, Safa S. Meshaal, Dalia S. Abd Elaziz, Marwa A. Elsharkawy, Radwa S. Alkady, Sohilla Lotfy, Ahmad El-Sheikhah, Amr Hassan, Nermeen M. Galal, Jeannette A. Boutros, Aisha M. Elmarsafy

Erschienen in: Molecular Diagnosis & Therapy | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary immunodeficiency disorders (PIDs) are a heterogeneous group of diseases of the immune system leading to life-threatening infections, and, unless urgently treated with immune reconstitution, patients do not usually survive. With the continuing progress in molecular diagnosis, many mutations have been described in more than 300 genes. Genetic counseling has recently been considered an essential part of the management of PIDs. This study presents the experience of genetic counseling services in the largest PID center in Egypt, and reports on our management plan and the impact of prenatal diagnosis (PND) on families.

Methods

Based on the biochemical and molecular diagnosis of index cases, PND was offered for 10 families in 12 subsequent pregnancies. Five different genes were sequenced by Sanger sequencing in fetal samples.

Results

Seven fetuses were either normal or were carriers, while five fetuses were affected and human leukocyte antigen typing was performed, seeking a suitably related donor for stem cell transplantation.

Conclusion

In spite of the genetic heterogeneity behind PIDs, genetic counseling should play a critical role in the management and future decisions of affected families.
Literatur
1.
Zurück zum Zitat Wessels T-M, Krause A. Genetic counselling in primary immunodeficiency disorders. Curr Allergy Clin Immunol. 2012;25:199–203. Wessels T-M, Krause A. Genetic counselling in primary immunodeficiency disorders. Curr Allergy Clin Immunol. 2012;25:199–203.
2.
Zurück zum Zitat Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696–726.CrossRefPubMedPubMedCentral Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696–726.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mishra A, Gupta M, Dalvi A, Ghosh K, Madkaikar M. Rapid flow cytometric prenatal diagnosis of primary immunodeficiency (PID) disorders. J Clin Immunol. 2014;34:316–22.CrossRefPubMed Mishra A, Gupta M, Dalvi A, Ghosh K, Madkaikar M. Rapid flow cytometric prenatal diagnosis of primary immunodeficiency (PID) disorders. J Clin Immunol. 2014;34:316–22.CrossRefPubMed
4.
Zurück zum Zitat Stembalska A, Ślęzak R, Pesz K, Gil J, Sasiadek M. Prenatal diagnosis: principles of diagnostic procedures and genetic counseling. Folia Histochem Cytobiol. 2007;45 Suppl 1:S11–6. Stembalska A, Ślęzak R, Pesz K, Gil J, Sasiadek M. Prenatal diagnosis: principles of diagnostic procedures and genetic counseling. Folia Histochem Cytobiol. 2007;45 Suppl 1:S11–6.
5.
Zurück zum Zitat Galal N, Meshaal S, El Hawary R, Abd Elaziz D, Alkady R, Lotfy S, et al. Patterns of primary immunodeficiency disorders among a highly consanguineous population: Cairo University pediatric hospital’s 5-year experience. J Clin Immunol. 2016;36:649–55.CrossRefPubMed Galal N, Meshaal S, El Hawary R, Abd Elaziz D, Alkady R, Lotfy S, et al. Patterns of primary immunodeficiency disorders among a highly consanguineous population: Cairo University pediatric hospital’s 5-year experience. J Clin Immunol. 2016;36:649–55.CrossRefPubMed
6.
Zurück zum Zitat Meshaal S, El Hawary R, Elsharkawy M, Mousa R, Farid R, Abd Elaziz D, et al. Mutations in recombination activating gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Clin Immunol. 2015;158:167–72.CrossRefPubMed Meshaal S, El Hawary R, Elsharkawy M, Mousa R, Farid R, Abd Elaziz D, et al. Mutations in recombination activating gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Clin Immunol. 2015;158:167–72.CrossRefPubMed
7.
Zurück zum Zitat Meshaal S, El Hawary R, Abd Elaziz D, Alkady R, Galal N, Boutros J, et al. Chronic granulomatous disease: review of a cohort of Egyptian patients. Allergol Immunopathol. 2015;43(3):279–85.CrossRef Meshaal S, El Hawary R, Abd Elaziz D, Alkady R, Galal N, Boutros J, et al. Chronic granulomatous disease: review of a cohort of Egyptian patients. Allergol Immunopathol. 2015;43(3):279–85.CrossRef
8.
Zurück zum Zitat El Hawary R, Meshaal S, Deswarte C, Abdelkawy M, Galal N, Alkady R, et al. Role of flow cytometry in the diagnosis of chronic granulomatous disease: the Egyptian experience. J Clin Immunol. 2016;36:610–8.CrossRefPubMed El Hawary R, Meshaal S, Deswarte C, Abdelkawy M, Galal N, Alkady R, et al. Role of flow cytometry in the diagnosis of chronic granulomatous disease: the Egyptian experience. J Clin Immunol. 2016;36:610–8.CrossRefPubMed
9.
Zurück zum Zitat El-Beshlawy A, El-Shekha A, Momtaz M, Said F, Hamdy M, Osman O, et al. Prenatal diagnosis for thalassaemia in Egypt: what changed parents’ attitude? Prenat Diagn. 2012;32:777–82.CrossRefPubMed El-Beshlawy A, El-Shekha A, Momtaz M, Said F, Hamdy M, Osman O, et al. Prenatal diagnosis for thalassaemia in Egypt: what changed parents’ attitude? Prenat Diagn. 2012;32:777–82.CrossRefPubMed
10.
Zurück zum Zitat Khera N, Zeliadt SB, Lee SJ. Economics of hematopoietic cell transplantation. Blood. 2012;120(8):1545–51.CrossRefPubMed Khera N, Zeliadt SB, Lee SJ. Economics of hematopoietic cell transplantation. Blood. 2012;120(8):1545–51.CrossRefPubMed
11.
Zurück zum Zitat Scheidel W. Brother-sister and parent-child marriage outside royal families in ancient Egypt and Iran: a challenge to the sociobiological view of incest avoidance? Ethol Sociobiol. 1996;17:319–40.CrossRef Scheidel W. Brother-sister and parent-child marriage outside royal families in ancient Egypt and Iran: a challenge to the sociobiological view of incest avoidance? Ethol Sociobiol. 1996;17:319–40.CrossRef
12.
Zurück zum Zitat Shawky RM, ElAwady M, Elsayed S, Hamadan G. Consanguinous matings among Egyptian population. Egypt J Med Hum Genet. 2012;12(2):157–63.CrossRef Shawky RM, ElAwady M, Elsayed S, Hamadan G. Consanguinous matings among Egyptian population. Egypt J Med Hum Genet. 2012;12(2):157–63.CrossRef
13.
Zurück zum Zitat Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2012;1(1):12–7.CrossRef Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2012;1(1):12–7.CrossRef
14.
Zurück zum Zitat Corneo B, Moshous D, Güngör T, Wulffraat N, Philippet P, Le Deist F, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood. 2001;97(9):2772–6.CrossRefPubMed Corneo B, Moshous D, Güngör T, Wulffraat N, Philippet P, Le Deist F, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood. 2001;97(9):2772–6.CrossRefPubMed
15.
Zurück zum Zitat Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, et al. A systematic analysis of recombination activity and genotype–phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133:1099–108.CrossRefPubMed Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, et al. A systematic analysis of recombination activity and genotype–phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133:1099–108.CrossRefPubMed
16.
Zurück zum Zitat Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16–26.CrossRefPubMed Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16–26.CrossRefPubMed
Metadaten
Titel
Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt
verfasst von
Rabab E. El Hawary
Safa S. Meshaal
Dalia S. Abd Elaziz
Marwa A. Elsharkawy
Radwa S. Alkady
Sohilla Lotfy
Ahmad El-Sheikhah
Amr Hassan
Nermeen M. Galal
Jeannette A. Boutros
Aisha M. Elmarsafy
Publikationsdatum
01.12.2017
Verlag
Springer International Publishing
Erschienen in
Molecular Diagnosis & Therapy / Ausgabe 6/2017
Print ISSN: 1177-1062
Elektronische ISSN: 1179-2000
DOI
https://doi.org/10.1007/s40291-017-0297-5

Weitere Artikel der Ausgabe 6/2017

Molecular Diagnosis & Therapy 6/2017 Zur Ausgabe

Acknowledgement to Referees

Acknowledgement to Referees

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.